Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07250750
PHASE1/PHASE2

A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis

Sponsor: ImmunAbs Inc.

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and potential efficacy of IM-101 in adult participants with AChR antibody-positive gMG. Subsequently, the safety and efficacy of the selected IM-101 dose-regimen will be tested in participants with AChR antibody-negative gMG and participants with AChR antibody-positive or AChR antibody-negative oMG.

Official title: A Phase 1b/2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Investigate A) the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses of IM-101 in Adult Participants With Generalized Myasthenia Gravis, and B) the Efficacy and Safety of Treatment of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis

Key Details

Gender

All

Age Range

18 Years - 74 Years

Study Type

INTERVENTIONAL

Enrollment

96

Start Date

2026-02-05

Completion Date

2028-06

Last Updated

2026-02-11

Healthy Volunteers

No

Interventions

DRUG

IM-101 Part A

Participants will receive IM-101 intravenously (IV), at a loading dose on Day 1 and Day 15 followed by maintenance dose and Day 29.

DRUG

Placebo Part A

Participants will receive Placebo intravenously (IV), at a loading dose on Day 1 and Day 15 followed by maintenance dose on Day 29.

DRUG

IM-101 Part B

Participants will receive IM-101 intravenously (IV), at a loading dose on Day 1 and Day 15 followed by maintenance dose on Day 29, D57 and D85.

DRUG

Placebo Part B

Participants will receive Placebo intravenously (IV), at a loading dose on Day 1 and Day 15 followed by maintenance dose on Day 29, D57 and D85.

Locations (25)

Neurology of Central Florida Research Center, LLC

Altamonte Springs, Florida, United States

SFM Clinical Research, LLC

Boca Raton, Florida, United States

Aqualane Clinical Research

Naples, Florida, United States

Medsol Clinical Research Center

Port Charlotte, Florida, United States

University of South Florida

Tampa, Florida, United States

University of Kansas Medical Center Research Institute, Inc.

Kansas City, Missouri, United States

Nerve & Muscle Center of Texas

Houston, Texas, United States

Houston Methodist Neurological Institute

Houston, Texas, United States

Medical Center Hera - branch Montana

Montana, Bulgaria

"MHAT Avis - Medica" OOD

Pleven, Bulgaria

UMHAT 'Dr. Georgi Stranski', EAD

Pleven, Bulgaria

UMHAT 'Tsaritsa Yoanna - ISUL', EAD

Sofia, Bulgaria

Haelan Care 4 Medical Center EOOD

Varna, Bulgaria

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (Presidio Spedali Civili)

Brescia, Brescia, Italy

Ospedale San Raffaele

Milan, Milano, Italy

Fondazione IRCCS Istituto Neurologico Carlo Besta

Milan, Milano, Italy

Neurologia Slaska Centrum Medyczne

Katowice, Poland

Twoja Przychodnia NCM

Nowa Sól, Poland

Twoja Przychodnia PCM

Poznan, Poland

NZOZ Neuro-Kard Ilkowski i Partnerzy Spółka Partnerska Lekarzy

Poznan, Poland

Samodzielny Publiczny Szpital Kliniczny nr 1 im. Prof. Stanislawa Szyszko, SUM

Zabrze, Poland

General Hospital MSB Medical System Belgrade

Belgrade, Serbia

Hospital Universitario Clinico San Carlos

Madrid, Madrid, Spain

Hospital Universitario La Paz

Madrid, Madrid, Spain

Clinica Universidad de Navarra

Pamplona, Navarre, Spain